These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32761844)

  • 1. Effects of resistance exercise on treatment outcome and laboratory parameters of Takayasu arteritis with magnetic resonance imaging diagnosis: A randomized parallel controlled clinical trial.
    Li G; Liu F; Wang Y; Zhao M; Song Y; Zhang L
    Clin Cardiol; 2020 Nov; 43(11):1273-1278. PubMed ID: 32761844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial.
    Shi G; Hua M; Xu Q; Ren T
    Immunobiology; 2017 Feb; 222(2):164-168. PubMed ID: 27771172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.
    Shao N; Jia H; Li Y; Li J
    Immunol Res; 2017 Aug; 65(4):969-974. PubMed ID: 28349250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
    Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
    Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
    Tamura N; Maejima Y; Tezuka D; Takamura C; Yoshikawa S; Ashikaga T; Hirao K; Isobe M
    J Cardiol; 2017 Sep; 70(3):278-285. PubMed ID: 27989502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.
    Kong X; Xu M; Cui X; Ma L; Cheng H; Hou J; Sun X; Ma L; Jiang L
    Front Immunol; 2021; 12():646516. PubMed ID: 34079541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home-Based Exercise Training in Childhood-Onset Takayasu Arteritis: A Multicenter, Randomized, Controlled Trial.
    Astley C; Clemente G; Terreri MT; Carneiro CG; Lima MS; Buchpiguel CA; Leão Filho H; de Sá Pinto AL; Silva CA; Campos LMA; Aikawa NE; Gil S; Pereira RMR; Roschel H; Gualano B
    Front Immunol; 2021; 12():705250. PubMed ID: 34394103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis.
    Karadeniz H; Güler AA; Koca G; Salman RB; Satış H; Ataş N; Babaoğlu H; Paşaoğlu H; Küçük H; Tufan A; Öztürk MA; Göker B; Haznedaroğlu Ş
    Clin Rheumatol; 2022 Apr; 41(4):1169-1176. PubMed ID: 35013833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis.
    Seringec Akkececi N; Yildirim Cetin G; Gogebakan H; Acipayam C
    Med Sci Monit; 2019 Feb; 25():1401-1409. PubMed ID: 30792377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis.
    Ma LY; Li CL; Ma LL; Cui XM; Dai XM; Sun Y; Chen HY; Huang BJ; Jiang LD
    Arthritis Res Ther; 2019 Jan; 21(1):24. PubMed ID: 30651132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity.
    Jain A; Kumar D; Guleria A; Misra DP; Zanwar A; Chaurasia S; Kumar S; Kumar U; Mishra SK; Goel R; Danda D; Misra R
    J Proteome Res; 2018 Sep; 17(9):3317-3324. PubMed ID: 30095916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).
    Misra R; Danda D; Rajappa SM; Ghosh A; Gupta R; Mahendranath KM; Jeyaseelan L; Lawrence A; Bacon PA;
    Rheumatology (Oxford); 2013 Oct; 52(10):1795-801. PubMed ID: 23594468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of novel inflammatory markers in takayasu arteritis and its correlation with disease activity.
    Pathadan AP; Tyagi S; Gupta MD; M P G; Mahajan S; Kunal S; Mahajan B; Bansal A
    Indian Heart J; 2021; 73(5):640-643. PubMed ID: 34627584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis.
    Dai D; Wang Y; Jin H; Mao Y; Sun H
    Rheumatol Int; 2017 Jul; 37(7):1083-1088. PubMed ID: 28364217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
    Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are monocyte-to-HDL and C-reactive protein-to-albumin ratios useful for the diagnosis and follow-up of Takayasu arteritis?
    Kılınç EA; Varkal G; Kırmızıer G; Türk İ; Özer HTE
    Rev Assoc Med Bras (1992); 2024; 70(5):e20231683. PubMed ID: 38775535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha -308G/A gene polymorphism and novel biomarker profiles in patients with Takayasu arteritis.
    Sarkar PG; Gupta MD; Girish MP; Bansal A; Kohli S; Saijpaul R; Tyagi S; Pasha Q
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S167-S172. PubMed ID: 30595251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mean platelet volume in patients with Takayasu arteritis.
    Peng YF; Guo J; Deng YB
    Ann Clin Biochem; 2017 Mar; 54(2):273-278. PubMed ID: 27329216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Takayasu arteritis in Thailand: clinical and imaging features.
    Suwanwela N; Piyachon C
    Int J Cardiol; 1996 Aug; 54 Suppl():S117-34. PubMed ID: 9119513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS).
    Hoffman GS; Ahmed AE
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S191-4; discussion S195. PubMed ID: 9951819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.